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ABSTRACT
Background    The desirable goals of the treatment of 
major depressive disorder (MDD) are considered both 
to achieve symptom remission and to help the patients 
be restored to their premorbid levels of functioning. Re-
mission has often been defined clinically as a threshold 
using standardized scales. Such a definition, however, 
allows several residual symptoms to be present in the 
remitted state. The aim of this study was to examine the 
relationship between the levels of residual symptoms 
and social functioning and also the relationship between 
residual symptoms and brain function. 
Methods    The subjects were 21 patients with MDD in 
remission, defined operationally using clinician-rated 
17-item Hamilton Depression Scale. Depressive symp-
toms and social functioning were self-assessed with the 
Japanese versions of the Center for Epidemiologic Stud-
ies Depression Scale (CES-D) and the Social Adapta-
tion Self-evaluation Scale (SASS), respectively. Brain 
function was measured by the changes in concentration 
of oxy-hemoglobin ([oxy-Hb]) in the prefrontal and 
temporal cortices during verbal fluency task using near-
infrared spectroscopy (NIRS).  
Results    The mean CES-D total score was 18.0, s = 
13.2, indicating that they have on average mild depres-
sion. Scores of CES-D total and those of its four factors 
showed a significantly negative correlation with the 
SASS total score. Among the four factors, “Interper-
sonal problems” factor showed the strongest correlation 
with it. CES-D total score and those of its three factors, 
“Depressed affect”, “Somatic and retarded activity” and 
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“Positive affect”, showed significantly negative correla-
tions with the mean [oxy-Hb] changes mainly in the left 
hemisphere, whereas “Interpersonal problems” factor 
showed a significantly positive correlation with the size 
of NIRS activation predominantly in right prefrontal re-
gions. 
Conclusion    Our results indicate that remitted patients 
with MDD possibly have residual symptoms which are 
most likely to impair their social functioning and that 
these symptoms are differentially associated with brain 
function measured with NIRS. 
Key words    major depressive disorder; near-infrared 
spectroscopy; prefrontal cortex; remission; residual 
symptoms
Major depressive disorder (MDD) is one of the serious 
health problems worldwide. From a currently prevailing 
view, MDD is assumed to be of a chronic or recurrent 
nature with many patients encountering enormous dif-
ficulty in achieving full remission.1 These properties 
may prevent them from returning to premorbid function-
ing levels.2 The desirable goals of its treatment thus are 
both to achieve symptom remission and to fully recover 
social functioning. To date, remission has been opera-
tionalized, however, in clinical trials as a cut-off score 
using standardized rating scale. Specifically, a score of 
7 or less on the 17-item Hamilton Depression Rating 
Scale (HAM-D17) typically designates remission.3 In 
large prospective study, 28% of the participants achieved 
remission after initial treatment4 with lower rates for 
those requiring subsequent treatment.5 As regards long-
term outcome, patients in remission at follow-up entry 
were shown to be less likely to relapse than those not in 
remission.5
 Although achieving remission is thus a highly rec-
ommended goal of the treatment of MDD in order for 
the patients to return to normal functioning, the serious 
problem is that patients who are in remission defined 
operationally do not necessarily achieve full recovery.6 
As such definitions do not require that patients be com-
pletely asymptomatic, they may have a varying degree 
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of residual symptoms. Many clinical studies have shown 
that the presence of residual symptoms is a strong pre-
dictor of relapse.7–9 Moreover, their presence may pre-
vent even remitted patients from functioning normally. 
In addition to common symptoms such as low mood and 
loss of interest, patients with MDD often have as residu-
al symptoms interpersonal difficulties as well, which are 
usually not used for the diagnosis10 but may nevertheless 
seriously hinder social functioning as well. The interper-
sonal problems have a pivotal role in the perpetuation of 
depressive symptoms11 with the efficacy of interpersonal 
therapy for MDD providing indirect evidence for its role 
in the maintenance of depression.12
 In addition to adversely affected mood, MDD is 
also characterized by impaired cognition.13 Neuropsy-
chological dysfunction contributes to poor functional 
outcome14: e.g., verbal fluency deficits were found to 
predict poor functioning. In previous study, we found 
a positive relationship between the verbal fluency task 
(VFT)-related hemodynamic responses in the prefrontal 
regions of MDD patients measured with near-infrared 
spectroscopy (NIRS) and levels of social functioning.15 
In addition, impaired cognition has been demonstrated 
irrespective of their current mood even in first-episode 
patients.16 These cognitive deficits are thus most likely 
to persist into the remitted state, and might compromise 
their social functioning possibly in association with re-
sidual symptoms. 
 We should then address the critical issues of charac-
terizing the clinical and pathophysiological nature of the 
residual symptoms, which are likely involved in the im-
paired functioning in a certain portion of remitted MDD 
patients. Little is known, however, about the relationship 
in remitted state of MDD between brain dysfunction and 
residual symptoms. In this pilot cross-sectional study, as 
the first approach to characterizing the possible relation-
ship of residual symptoms with brain function and social 
functioning, we performed NIRS measurements during 
VFT period in MDD patients in operationally defined 
remission using clinician-assessed HAM-D17.7 Self-re-
port depressive symptoms were also examined with the 
Japanese version of the Center for Epidemiologic Stud-
ies Depression Scale (CES-D),17 which is assumed to be 
the only instrument that assesses interpersonal aspects 
besides common symptoms. When using VFT as a task, 
NIRS is approved for application in clinical practice for 
assisting differential diagnosis of depression in Japan 
because attenuated VFT-related prefrontal activation 
in depressed MDD patients is a consistent finding.15, 18 
It is therefore well established that VFT-related NIRS 
signals are a useful tool for evaluating the pathophysi-
ological aspects of MDD. We hypothesized that, even in 
remitted MDD patients, certain residual symptoms are 
associated with impaired psychosocial functioning, and 
that impaired brain activity in the prefrontal or temporal 
cortical regions underlies these residual symptoms. 
SUBJECTS AND METHODS 
Subjects (Table 1)
Twenty-one euthymic patients with MDD (7 males, 14 
females) were enrolled in the study after they provided a 
written informed consent. All the patients were recruited 
from among the outpatients at Tottori University Hos-
pital. They had been diagnosed with MDD during their 
clinical course based on the Diagnostic and Statistical 
Manual of Mental Disorders, fourth edition19 using the 
Mini-International Neuropsychiatric Interview (MINI).20 
They were also demonstrated at study initiation to have 
been in the state of remission for at least one month, de-
fined as a score of seven or less on the HAM-D173 eval-
uated by two trained psychiatrists. None of the subjects 
had clinical evidence of other central nervous system 
disorders based on history and medical examination. Pa-
tients with previous head trauma, stroke, electroconvul-
sive therapy, and current or previous history of substance 
abuse were excluded from the study. All the participants 
were right-handed by the criterion on the Edinburgh 
Inventory Index21 and were native speakers of Japanese. 
The study was approved by the Ethics Committee of 
Tottori University Faculty of Medicine and the investiga-
tion was carried out in accordance with the latest version 
of the Declaration of Helsinki.
Clinical Assessment 
Prior to NIRS measurement, all the participants self-
assessed depression symptom with the Japanese ver-
sion of the CES-D scale.17 This scale consists of twenty 
questions which measure depressive symptomatology 
during the past week. Respondents rate the frequency of 
occurrence of each symptom on a 4-point Likert scale (0: 
less than 1 day; 1: last for 1–2 days; 2: last for 3–4 days; 
and 3: last for 5–7 days). The scores for each item can be 
summed to give a total score ranging from 0 to 60 with 
higher scores indicating more severe depression. Based 
on the total score, patients can be categorized as hav-
ing mild depression (score 16 to 26) or major depression 
(score 27 to 60). The CES-D has been shown to consist 
of four factors, namely “Depressed affect”, “Positive af-
fect”, “Somatic and retarded activity” and “Interpersonal 
problems”.22 
 All the subjects also self-assessed the Japanese version 
of social functioning with the Social Adaptation Self-Eval-
uation Scale (SASS), which is a 21-item scale developed 
for the evaluation of patients’ social functioning by Bosc 
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et al.23; the reliability and validity of the Japanese ver-
sion have been confirmed.24 Levels of social functioning 
were also objectively evaluated with Global Assessment 
of Functioning (GAF) scale by a trained psychiatrist.
Activation task
The task procedure in this study was similar to that of 
Takizawa et al.25 The changes in concentration of oxy-
hemoglobin ([oxy-Hb]) were measured during VFT (let-
ter version). Each subject sat on a comfortable chair and 
was instructed to minimize movement during the NIRS 
measurements so as to avoid artifacts. The activation 
task included a 30-s pre-task baseline, a 60-s VFT and a 
70-s post-task baseline. For the two baseline periods, the 
subjects repeat the five Japanese vowels (“a”, “i”, “u”, “e”, 
“o”) aloud. The subtraction method (task minus pre- and 
post-task baseline) minimized the vocalization effects 
during VFT. During VFT period, they were instructed 
to generate as many Japanese words beginning with a 
designated syllable as possible. The three sets of initial 
syllables (A; /to/, /se/, /o/, B; /a/, /ki/, /ha/, C; /na/, /i/, /
ta/) were presented in counterbalanced order among the 
subjects and each syllable changed every 20 s during the 
60-s task. The total number of correct words generated 
was adopted as a measure of performance.
NIRS measurements
The 52-channel NIRS machine (ETG-4000; Hitachi 
Medical, Tokyo, Japan) measures relative changes in 
[oxy-Hb] and concentration of deoxy-hemoglobin us-
ing two wavelengths (695 and 830 nm) of infrared light 
based on the modified Lambert-Beer law. In this con-
tinuous-wave NIRS system, these [Hb] values include a 
differential pathlength factor; therefore, the unit of NIRS 
measurement is mM·mm. The distance between pairs 
of source detector probes was set at 3.0 cm and each 
measuring area between them was defined as ‘channel’. 
It is considered that the machine measures the surface 
regions of the cerebral cortex.26 The probes of the NIRS 
machine were placed on a subject’s fronto-temporal re-
gion with the mid column of the probe located over Fpz, 
and the lowest probes are located along the T3–Fp1–
Fpz–Fp2–T4 line in accordance with the international 
10/20 system used in electroencephalography. Their ar-
rangement enabled the measurement of concentration of 
hemoglobin values from bilateral prefrontal and superior 
temporal cortical surface regions. The correspondence 
between the NIRS channels and the measurement points 
on the cerebral cortex was confirmed by the previous 
study that performed simultaneous recording of NIRS 
and functional magnetic resonance imaging.27 The sam-
pling rate was 0.1 s. The obtained data were analyzed 
using the “integral mode”; the pre-task baseline was 
determined as the mean over a 10-s period prior to the 
VFT period, and the post-task baseline as the mean over 
the last 5 s of the post-task period. 
Statistical analysis
When making a comparison of SASS total score be-
tween the two groups of differing CES-D total score 
(0–15, the group without depression, termed as “ND” 
vs. 16–60, the group with depression, termed as “D”), 
Student’s t-test was performed. Additionally, we investi-
gated the relationships between these clinical or psycho-
social variables using Spearman’s ρ because the scores 
of CES-D total and individual factors did not show nor-
mal distribution.
 We then tested the relationships between the clinical 
variables and the mean [oxy-Hb] change during the VFT 
period for each channel. The clinical and psychosocial 
variables assessed were as follows: HAM-D17, CES-
D, SASS and GAF. As regards CES-D, each score of its 
four factors were tested for its correlation with the mean 
task-related [oxy-Hb] change as well as the total score. 
We investigated these relationships using Spearman’s ρ 
as well. 
 All the statistical analyses were performed using 
SPSS 21.0 software. A P value of < 0.05 was considered 
statistically significant. The multiplicity of the correla-
tion analyses including NIRS data from 52 channels was 
not corrected, and the results should therefore be taken 
as exploratory.
RESULTS
Demographic and clinical data of patients in re-
mission
Table 1 summarizes demographic characteristics and 
clinician-rated severity (HAM-D17) of depressive symp-
tom in the remitted MDD patients. Only patients with 
HAM-D17 score of 7 or less for more than one month 
were eligible for the present study.
Residual depressive symptoms and social func-
tioning
Table 2 summarizes self-report severity of depression 
symptom (CES-D), self- and clinician-rated social func-
tioning, SASS and GAF, respectively and task perfor-
mance on the VFT. In MDD patients who were opera-
tionally classified as being in the state of remission, the 
mean CES-D total score was 18.0, s = 13.2, indicating 
that the self-report severity of residual symptoms in this 
sample were yet in the range of mild depression on aver-
age. The numbers of the participants classified into each 
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of the two categories of mood state were as follows: i) 
twelve in “ND” (range of CES-D total score, 0–15) and 
ii) nine in “D” (16–60). Any combination of two factors 
within CES-D scale showed a significant, positive corre-
lation between one another (ρ = 0.45 to 0.88, P = 0.00001 
to 0.02). 
Relationships between severity of residual symp-
toms and degrees of psychosocial impairment 
(Table 3)
When subdividing the participants into the two sub-
groups based on the CES-D total score, that is, “ND” 
(0–15) and “D” (16–60), SASS total score was signifi-
cantly higher in “ND” than in “D” (“ND”, mean 40.5, s 
= 7.7 vs. “D”, mean 30.4, s = 8.6, P < 0.05). In contrast, 
Table 3. Correlational analyses between severity of 
depression and social functioning
Severity of depressive symptoms Social functioning
SASS GAF
CES-D total –0.57* –0.42
Depressed affect –0.54** –0.45*
Somatic and retarded activity –0.63*** –0.25
Interpersonal problems –0.65*** –0.70****
Positive affect –0.51* –0.50*
HAM-D17 total –0.45* –0.54*
Values are expressed as Spearman’s ρ. 
*P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.001.
CES-D, Center for Epidemiologic Studies Depression Scale; GAF, 
Global Assessment of Functioning; HAM-D17, 17-item Hamilton 
Depression Rating Scale; SASS, Social Adaptation Self-Evalua-
tion Scale.
Table 1. Clinical and demographic characteristics of 
the remitted patients with MDD
Remitted MDD
patients (n = 21)
Age (years old) 59.4 ± 12.0 (32–81)
Gender (male/female) 7/14
Education (years) 12.3 ± 2.1 (9–16)
Estimated premorbid IQ 101.9 ± 15.0 (73–120)
HAM-D17 total score 2.8 ± 2.5 (0–7)
Medication
Imipramine equivalent dose (mg/day) 85.7 ± 71.5 (0–300)
Values are expressed as mean ± s (range).
HAM-D17, 17-item Hamilton Depression Rating Scale; IQ, intel-
ligence quotient; MDD, major depressive disorder.
Table 2. Self-assessed residual symptoms, social 
functioning and task performance
Remitted MDD
patients (n = 21)
CES-D total 18.0 ± 13.2 (0–47)
Depressed affect 4.4 ± 5.2 (0–17)
Somatic and retarded activity 4.8 ± 4.6 (0–14)
Interpersonal problems 1.0 ± 1.6 (0–6)
Positive affect 7.8 ± 3.7 (0–12)
SASS 34.1 ± 10.1 (18–56)
GAF 80.3 ± 9.8 (61–100)
VFT performance (words generated) 12.3 ± 4.0 (5–18)
Values are expressed as mean ± s (range). 
CES-D, The Center for Epidemiologic Studies Depression Scale; 
GAF, Global Assessment of Functioning; MDD, major depressive 
disorder; SASS, Social Adaptation Self-Evaluation Scale; VFT, 
verbal fluency task.
GAF scores of the two groups were of similar levels 
(“ND”, mean 83.3, s = 7.5 vs. “D”, mean 76.2, s = 11.5, 
P = 0.13). 
 Levels of self-assessed residual symptoms were cor-
related with those of SASS (Table 3): Scores of the CES-
D total and of any of its individual factors showed a sig-
nificant negative correlation with the SASS total score. 
Among these factors, “Interpersonal problems” factor 
showed the strongest correlation with the SASS total 
score. In contrast, CES-D total score merely indicated 
a trend towards a correlation with clinician-rated GAF 
score (ρ = –0.42, P = 0.06). Of its four factors, levels 
of three factors were significantly negatively correlated 
with the GAF score with “Interpersonal problems” fac-
tor again showing the strongest association (Table 3). 
HAM-D17 total score was also significantly correlated 
with either scale for social functioning, although with 
much smaller significance compared with most indi-
vidual factors of CES-D (Table 3).  
Cognitive task-related changes in [oxy-Hb] chang-
es
The mean VFT-related [oxy-Hb] changes averaged 
across 11 channels in the prefrontal region was 0.03, s = 
0.06 (in mM·mm) in the remitted MDD patients group 
(n = 21). Those values averaged across 10 channels each 
in the left and right temporal regions were 0.07, s = 0.10 
and 0.08, s = 0.10, respectively. 
 The mean VFT-related [oxy-Hb] changes in the 
prefrontal region were roughly comparable when clas-
sifying the subjects into two subgroups, “ND” and “D”, 
whereas those in the bilateral temporal regions showed 
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a trend to be larger in “ND” than in “D” : i) prefrontal 
region; “ND”, mean 0.03, s = 0.05 vs. “D”, mean 0.02, s 
= 0.06, P = 0.92, ii) right temporal region; “ND”, mean 
0.11, s = 0.10 vs. “D”, mean 0.05, s = 0.09, P = 0.14, iii) 
left temporal region, “ND”, mean 0.11, s = 0.09 vs. “D”, 
mean 0.03, s = 0.08, P = 0.06. 
Relationship between VFT-related [oxy-Hb] chang-
es and demographic and clinical variables.
In remitted patients, the mean task-related [oxy-Hb] 
changes were not significantly correlated with any of 
demographic variables except for a negative correlation 
with imipramine-equivalent doses in four channels: 
ch15, ch25, ch36 and ch48. The hemodynamic responses 
were not correlated with clinician-rated HAM-D total 
scores either except for single channel 33 (ch33). On 
the other hand, scores of CES-D total and its two fac-
tors showed significantly negative correlations with the 
responses at multiple channels mainly in the left hemi-
sphere: CES-D total in two channels (ch41 and ch52; ρ 
= –0.50 and –0.45, respectively; P = 0.03 to 0.04); “De-
pressed affect” in three channels (Fig. 1A and 1C; ch31, 
ch41 and ch52; ρ = –0.53 to –0.48; P = 0.01 to 0.03); 
“Somatic and retarded activity” in five channels (ch31, 
ch34, ch41, ch44 and ch52; ρ = –0.60 to –0.44; P = 0.01 
to 0.05). In contrast, “Interpersonal problems” showed 
a positive correlation with the NIRS activation in five 
channels located in the bilateral prefrontal regions (Figs. 
1A and 1B; ch14, ch17, ch35, ch36 and ch47; ρ = 0.49 
to 0.55; P = 0.01 to 0.02). Among the channels whose 
hemodynamic responses were likely affected by medi-
cation, only ch36 was related to the severity of residual 
symptoms with the responses there being positively 
associated exclusively with “Interpersonal problems” 
factor. Medication dose, however, did not show any cor-
relation with the levels of this factor at all (ρ = 0.10, P = 
0.66), excluding the possibility that medication mediated 
the close association between the brain activation and 
the symptom severity.   
 The distribution pattern of the NIRS channels cor-
related with the symptom severity indicated differential 
associations of distinct self-assessed residual symptoms 
Fig. 1. Relationship between the amount of VFT-related [oxy-Hb] changes and severity of self-report residual symptoms in remitted 
patients with MDD. A: The brain regions depicted in yellow and green correspond to the NIRS channels that exhibited a significant 
positive correlation (Spearman’s rank-order correlation; P < 0.05) between the degrees of NIRS activation and scores of “Interpersonal 
problems” (yellow) and “Depressed affect”, respectively, factors of CES-D. B: Representative scatter diagram at channel 47 (right orbito-
frontal and frontopolar cortical regions; Spearman’s rank correlation; ρ = 0.53 and P = 0.017). C: Representative scatter diagram at chan-
nel 52 (left superior and middle temporal cortical regions; Spearman’s rank correlation; ρ = –0.50 and P = 0.020). The location of NIRS 
channels were estimated and labeled anatomically in the standard brain space in accordance with Sato et al.27  
CES-D, Center for Epidemiologic Studies Depression Scale; MDD, major depressive disorder; NIRS, near-infrared spectroscopy; [oxy-
Hb], concentration of oxy-hemoglobin; VFT, verbal fluency task.
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of MDD with task-related brain activation in the cortical 
regions: i) CES-D total, “Depressed affect” and “Somatic 
and retarded activity” factors predominantly in left tem-
poral and ventrolateral prefrontal regions and ii) “Inter-
personal problems” factor mainly in right dorsolateral, 
orbitofrontal and frontopolar prefrontal regions. There 
was no overlap in the distribution of the correlated NIRS 
channels between these two symptom groups.  
DISCUSSION
The present study showed that MDD patients presumed 
to be in the state of symptom remission defined as a 
score of seven or less on the clinician-rated HAM-
D17 nevertheless self-reported a mild level of residual 
symptoms on the CES-D scale on average, and that the 
severity of the residual symptoms was negatively cor-
related with levels of social functioning self-rated with 
SASS. Moreover, VFT-related hemodynamic responses 
measured with NIRS revealed differential associations 
between the distinct residual symptoms and the hemody-
namic responses in different brain regions. Specifically, 
scores of CES-D total and of its two factors, “Depressed 
affect” and “Somatic and retarded activity”, were nega-
tively correlated with the activation chiefly in the left 
temporal regions, whereas the relationship was some-
what reverse for “Interpersonal problems”, that is, posi-
tive correlations in the multiple prefrontal subregions. 
These findings indicate that residual symptoms may 
compromise levels of social functioning even in a cer-
tain subpopulation of patients in operationally defined 
remission, and that the residual symptoms were possibly 
linked with dysfunctional task-related neuronal activa-
tion in the prefrontal and temporal cortical regions.  
 Although remission is commonly defined us-
ing cut-off score on a rating scale for depressive 
symptoms,3,defining it this way has been shown to not 
identify a relatively homogeneous group of patients as 
for morbidity and functioning. Judd et al.8 have found 
that remitted MDD patients with residual symptoms 
were at greater risk for relapse and had more severe psy-
chosocial impairment than those without them. Partici-
pants of the present study were also found to be rightly 
subdivided into two subgroups based on the CES-D total 
score, which may be justified on the grounds of clear 
negative correlation between residual symptoms and of 
self-rated social functioning. Such associations were also 
observed for any of the four factors of CES-D with “In-
terpersonal problems” factor exhibiting much stronger 
association than the other factors representing common 
depressive symptoms. “Interpersonal problems” factor 
is made up of the two items, “people were unfriendly” 
and “I felt that people dislike me”, both of which may 
be rightly interpreted to examine the aspect of interper-
sonal sensitivity28 or rejection sensitivity29 in depression. 
Importantly, interpersonal life events have been shown 
to predict persistence of depressive symptoms in MDD 
patients.30 The present finding thus indicated the im-
portance of evaluating this crucial aspect even in remit-
ted patients when considering the likely impairment in 
psychosocial functioning due to relationship problems, 
although the items that tap into this aspect have not been 
included in the common rating scale, and thus not been 
routinely examined in the clinical practices. However, 
it should also be borne in mind that rejection sensitivity 
may be trait-dependent rather than state-dependent.  
 As regards the cross-sectional relationship between 
the self-report residual symptoms (CES-D) and the [oxy-
Hb] activation in the remitted MDD patients, NIRS 
measurements during VFT task period revealed differ-
ential associations between the distinct residual symp-
toms of depression and brain activations in the fronto-
temporal cortical regions: scores of CES-D “Interper-
sonal problems” factor were positively correlated with 
the extent of the activation predominantly in the right 
prefrontal cortex (PFC), whereas those of “Somatic and 
retarded activity” and “Depressed affect” factors were 
negatively correlated with it mainly in the left temporal 
cortex. These distinct cortical distributions of the as-
sociated channels were such that there was not a partial 
overlap in these channels between the two groups of 
residual symptoms. This apparent lack of overlap in the 
distribution of the correlated channels suggests the pos-
sible involvements of distinct neural networks in the per-
sistence of different class of residual symptoms into the 
remitted state. As the amount of mean task-related [oxy-
Hb] changes in the remitted MDD patients in this study 
was of a comparable level to that of patients in current 
depression, which we previously examined in similar 
research settings,15, 31, 32 the patients in this study may 
well be considered to be associated with more attenuated 
activation than healthy population. These results, taken 
together, suggest that, even in remitted patients, residual 
symptoms are related to dysfunction of frontal and/or 
temporal cortices, although causal relationship cannot 
be determined due to the cross-sectional nature of this 
study. As the physiological dysfunction in the PFC in 
MDD patients with ongoing symptoms has been increas-
ingly clarified by functional neuroimaging studies,33–35 
our results suggest that such dysfunction persist into the 
remitted state. As for currently depressed patients, many 
cross-sectional studies, however, failed to find their as-
sociation when generally assessing symptom severity 
with total score of HAM-D17.15, 36, 37 By contrast, using 
self-assessed CES-D scale and its four factors,22 the 
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present study indicated possible associations between 
symptom severity and pathophysiological responses in a 
remitted MDD sample, although the distribution of cor-
related regions exhibited a rather complex pattern. The 
temporal and ventrolateral cortical regions in the left 
hemisphere associated negatively with the two factors, 
“Somatic and retarded activity” and “Depressed affect”, 
topographically overlapped to some extent. This finding 
suggests the possibility of shared pathophysiology of 
these two classes of residual symptoms. Similar associa-
tions were previously shown in these brain regions of 
MDD patients with ongoing depression as for “Psycho-
motor retardation” item on the HAM-D scale.35 In this 
context, it is noteworthy that a meta-analytic study by 
Fitzgerald et al.38 demonstrated dysfunctional activity 
at rest of superior and middle temporal gyri and ventro-
lateral cortex in MDD patients. This might support the 
aforementioned idea of the persistence of pathophysiol-
ogy underlying current depression into remitted state. 
On the other hand, “Interpersonal problems” factor were 
positively associated with the activation in wide regions 
of the PFC including dorsolateral prefrontal cortex 
(DLPFC), frontopolar PFC and orbitofrontal PFC. Two 
possible mechanisms are suggested to be involved in this 
observation. First, impaired DLPFC function may have 
a role for its inefficient activation. Recent studies suggest 
that DLPFC-mediated cognitive control may pertain to 
the regulation of negative emotion through reappraisal.39 
Considering the coexistence of “Interpersonal problems” 
and “Depressed affect” in certain remitted patients as 
suggested by a strong association between these symp-
toms, regulation of negative emotion, such as rejection 
sensitivity, by the DLPFC was likely to just partially 
work despite its greater activation. Second, reduced de-
activation of the prefrontal network functionally related 
to social relationships may be associated with rejection 
sensitivity. As rejection sensitivity is known to predict 
increased depressive rumination,29 which is defined 
as repetitive self-focused brooding, elevated scores of 
“Interpersonal problems” factor might reflect ongoing 
ruminative thinking in certain MDD patients. Recently 
it has been shown that the brain’s default mode network 
(DMN), whose normal activity is mostly correlated in 
the resting state and suppressed by external task require-
ments,40 is closely involved in the pathophysiology of 
depressive rumination.41, 42 DMN consists mainly of 
medial frontal structures, which appears to make it dif-
ficult for NIRS to directly measure its activity. Sasai et 
al.43 have demonstrated, however, that [oxy-Hb] changes 
measured with NIRS in the ventral prefrontal region 
partly reflect correlated activity of DMN. Attenuated 
suppression of DMN by VFT might thus partly con-
tribute to the observed association. As the attenuation 
is a possible predictor of relapse,44 symptoms resulting 
from dysfunctional DMN might be of a clinical impor-
tance. Longitudinal studies are required to investigate 
the predictability of outcome by symptoms representing 
impaired social relationships in remitted MDD patients.
 Finally, the current study has a number of limita-
tions. First, the sample size of the present study was rela-
tively small, which implies that our findings may not be 
generalizable to the broader population. Second, we did 
not make a direct comparison of the size of brain activa-
tion between our remitted MDD sample and those with 
current depression. However, our previous findings on 
currently depressed patients indicate the comparable size 
of the activation for the two groups.15, 31, 32 Third, the ef-
fects of multiple comparison tests were not considered in 
the correlation analyses, indicating that the findings are 
at best explorative. Finally, the cross-sectional design of 
this study was not intended to resolve the causal relation-
ship between residual symptoms of depression and he-
modynamic responses assessed with NIRS. This design 
also prevented us from determining whether residual 
symptoms, “Interpersonal problems” factor in particular, 
are best recognized as trait or state dependent. Future 
longitudinal studies of the relationships between changes 
in NIRS data and those in residual symptoms should be 
undertaken to address these problems. 
 In conclusion, a subpopulation of MDD patients in 
remission operationally defined with a threshold using 
HAM-D17 self-reported several residual symptoms of 
depression, the degrees of which were found to be posi-
tively correlated with the levels of self-assessed social 
functioning. In addition these symptoms were suggested 
to be differentially associated with dysfunction of corti-
cal regions. 
Acknowledgments: This study was supported by Intramural Re-
search Grant for Tottori University Hospital. The authors thank all 
the participants in this study. The authors also thank Dr. Yamada 
T for critically reading the manuscript and the Hitachi Medical 
Corporation for providing us with technical advice.
The authors declare no conflict of interest. 
REFERENCES
  1 Richards D. Prevalence and clinical course of depression: a 
review. Clin Psychol Rev. 2011;31:1117-25. PMID: 21820991. 
  2 Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, 
Daniels M, et al. The functioning and well-being of depressed 
patients. Results from the medical outcome study. JAMA. 
1989;262:914-9. PMID:2754791.
  3 Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, 
Lavori PW, et al. Conceptualization and rationale for consen-
22
M. Masai et al.
sus definitions of terms in major depressive disorder: remis-
sion, recovery, relapse and recurrence. Arch Gen Psychiatry. 
1991;48:851-5. PMID: 1929776.
  4 Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, 
Warden D, Ritz L, et al. Evaluation of Outcomes With Cita-
lopram for Depression Using Measurement-Based Care in 
STAR*D: Implications for Clinical Practice. Am J Psychiatry. 
2006;163:28-40. PMID: 16390886.
  5 Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR. 
The Star*D Project results: a comprehensive review of find-
ings. Curr Psychiatry Rep. 2007;9:449-59. PMID: 18221624.
  6 Zimmerman M, Posternak MA, Chelminski I. Heterogeneity 
among depressed outpatients considered to be in remission. 
Compr Psychiatry. 2007;48:113-7. PMID: 17292700.
  7 Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A. 
Residual symptoms after partial remission: an important out-
come in depression. Psychol Med. 1995;25:1171-80. PMID: 
8637947.
  8 Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, 
Coryell W, et al. Major depressive disorder: A prospective 
study of residual subthreshold depressive symptoms as predic-
tor of rapid relapse. J Affect Disord. 1998;50:97-108. PMID: 
9858069.
  9 Pintor L, Gasto C, Navarro V, Torres X, Fananas L. Relapse of 
major depression after complete and partial remission during 
a 2-year follow-up. J Affect Disord. 2004;73:237-44. PMID: 
12547292.
10 Peselow ED, Sanfilipo MP, Fieve RR, Gulbenkian G. Person-
ality traits during depression and after Clinical recovery. Br J 
Psychiatry. 1994;164: 349-354. PMID: 8199788.
11 Coyne JC. Toward an interactional description of depression. 
Psychiatry. 1976;39:14-27. PMID: 1257353.
12 Markowitz JC. Developments in interpersonal psychotherapy. 
Can J Psychiatry. 1999;44:556-61. PMID: 10497697.
13 Zakzanis KK, Leach L, Kaplan E. On the nature and pat-
tern of neurocognitive function in major depressive disorder. 
Neuropsychiatry, Neuropsychol, Behav Neurol. 1998;11:111-9. 
PMID: 9742509.
14 Jaeger J, Berns S, Uzelac S, Davis-Conway S. 2006. Neuro-
cognitive deficits and disability in major depressive disorder. 
Psychiatry Res. 2006;145: 39-48. PMID:17045658.
15 Pu S, Matsumura H, Yamada T, Ikezawa S, Mitani H, Adachi A, 
et al. Reduced frontopolar activation during verbal fluency 
task associated with poor social functioning in late-onset 
major depression: a multi-channel near-infrared spectroscopy 
study. Psychiatry Clin Neurosci. 2008;62:728-37. PMID: 
19068011.
16 Lee RSC, Hermens DF, Porter MA, Redoblado-Hodge MA. 
A meta-analysis of cognitive deficits in first-episode major 
depressive disorder. J Affect Disord. 2012;140:113-24. PMID: 
22088608.
17 Shima S, Shikano T, Kitamura T, Asai M. New self-rating 
scales for depression. Clinical Psychiatry. 1985;27:717-23. 
Japanese. 
18 Matsuo K, Onodera Y, Hamamoto T, Muraki K, Kato N, 
Kato T. Hypofrontality and microvascular dysregulation in 
remitted late-onset depression assessed by functional near-
infrared spectroscopy. Neuroimage. 2005;26:234-42. PMID: 
15862223. 
19 American Psychiatric Association. Diagnostic and statistical 
manual of mental disorders. 4th ed. Washington DC: Ameri-
can Psychiatric Association; 1994.
20 Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, 
Janavs J, Weiller E, et al. The Mini-International Neuropsy-
chiatric Interview M.I.N.I.: the development and validation 
of a structured diagnostic psychiatric interview for DSM-
IV and ICD-10. J Clin Psychiatry. 1998;59 (Suppl. 20) 22-33. 
PMID:9881538. 
21 Oldfield RC.1991. The assessment and analysis of handedness: 
the Edinburgh inventory. Neuropsychologia. 1991; 9: 97-113. 
PMID: 5146491.
22 Radloff LS. The CES-D scale: a self-report depression scale 
for research in the general population. Appl Psychol Meas. 
1977;1:385-401. 
23 Bosc M, Dubini A, Polin V. Development and validation of a 
social functioning scale, the Social Adaptation Self-evaluation 
Scale. Eur Neuropsychopharmacol. 1997;7 (Suppl. 1):S57-70. 
PMID: 9169311.
24 Goto M, Ueda N, Yoshimura R, Kihara S, Kaji K, Yamada Y, 
et al. Reliability and validity of the Japanese version of the 
social adaptation self-evaluation scale (SASS). Clincal Psy-
chiatry 2005;47:483-9. Japanese. 
25 Takizawa R, Kasai K, Kawakubo Y, Marumo K, Kawasaki S, 
Yamasue H, et al. Reduced frontopolar activation during 
verbal fluency task in schizophrenia: a multichannel near-
infrared spectroscopy study. Schizophr Res. 2008;99:250-62. 
PMID: 18063344.
26 Toronov V, Webb A, Choi JH, Wolf M, Michalos A, 
Gratton E, et al. Investigation of human brain hemodynamics 
by simultaneous near-infrared spectroscopy and functional 
magnetic resonance imaging. Med Phys. 2001;28:521-7. 
PMID: 11339749.
27 Sato H, Yahata N, Funane T, Takizawa R, Katura T, 
Atsumori H, et al. A NIRS-fMRI investigation of prefrontal 
cortex activity during a working memory task. Neuroimage. 
2013;83:158-73. PMID: 23792984.
28 Davidson J, Zisook S, Giller E, Helms M. Symptoms of inter-
personal sensitivity in depression. Compr Psychiatry. 1989;30: 
357-68. PMID: 2676337.
29 Pearson KA, Watkins ER, Mullan EG. Rejection sensitivity 
prospectively predicts increased rumination. Behav Res Ther. 
2011;49:597-605. PMID: 21764037.
30 Enns MW, Cox BJ. Psychosocial and clinical predictors of 
symptom persistence vs remission in major depressive disor-
der. Can J Psychiatry. 2005; 50:769-77. PMID: 16408525.
31 Pu S, Matsumura H, Yamada T, Ikezawa S, Mitani H, 
Adachi A, Nakagome K, et al. Prefrontal activation predicts 
social functioning improvement after initial treatment in late-
onset depression. J Psychiatr Res. 2015; 62:62-70. PMID: 
25659188.
32 Pu S, Nakagome K, Yamada T, Yokoyama K, Matsumura H, 
Yamada S, et al. Suicidal ideation is associated with reduced 
prefrontal activation during a verbal fluency task in patients 
with major depressive disorder. J Affect Disord. 2015; 181:9-
17. PMID: 25913539.
33 Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, 
Vannier M, et al. Subgenual prefrontal cortex abnormalities in 
mood disorders. Nature. 1997;386:824-7. PMID: 9126739.
34 Okada G, Okamoto Y, Morinobu S, Yamawaki S, Yokota N. At-
tenuated left prefrontal activation during a verbal fluency task 
in patients with depression. Neuropsychobiology. 2003;47:21-
6. PMID: 12606841.
35 Noda T, Yoshida S, Matsuda T, Okamoto N, Sakamoto K, 
Koseki S, et al. Frontal and right temporal activations corre-
late negatively with depression severity during verbal fluency 
task: a multi-channel near-infrared spectroscopy study. J Psy-
23
Residual symptoms in remitted depression
chiatr Res. 2012;46:905-12. PMID: 22572569.
36 Tsujii N, Mikawa W, Akashi H, Tsujimoto E, Adachi T, 
Kirime E, et al. Right temporal activation differs between 
melancholia and nonmelancholic depression: a multichannel 
near-infrared spectroscopy study. J Psychiatr Res. 2014;55:1-7. 
PMID: 24780385
37 Ohtani T, Nishimura Y, Takahashi K, Ikeda-Sugita R, Okada N, 
Okazaki Y. Association between longitudinal changes in 
prefrontal hemodynamic responses and social adaptation in 
patients with bipolar disorder and major depressive disorder. J 
Affect Disord. 2015;176:78-86. PMID: 25702603.
38 Fitzgerald PB, Laird AR, Maller J, Daskalakis ZJ. A meta-
analytic study of changes in brain activation in depression. 
Hum Brain Mapp. 2008;29:683-95. PMID: 17598168.
39 Eippert F, Veit R, Weiskopf N. Erb M, Birbaumer N, Andres S. 
Regulation of emotional responses elicited by threat-related 
stimuli. Hum Brain Mapp. 2007;28:409-23. PMID: 17133391.
40 Reichle ME, Macleod AM, Snyder AZ, Powers WJ, 
Gusnard DA, Shulman GL. A default mode of brain function. 
Proc Natl Acad Sci USA. 2001;98:676-82. PMID: 11209064.
41 Dutta A, McKie S, Deakin JFW. Resting state networks in 
major depressive disorder. Psychiatry Res. 2014;224:139-51. 
PMID: 25456520. 
42 Zhu X, Wang X, Xiao J, Liao J, Zhong M, Wang W, et al. Evi-
dence of a dissociation pattern in resting-state default mode 
network connectivity in first-episode, treatment-naive major 
depression patients. Biol Psychiatry. 2012;71:611-7. PMID: 
22177602.
43 Sasai S, Homae F, Watanabe H, Sasaki AT, Tanabe HC, 
Sadato N, et al. A NIRS-fMRI study of resting state network. 
Neuroimage. 2012;63:179-93. PMID: 22713670.
44 Bartova L, Meyer BM, Diers K, Rabl U, Scharinger C, 
Popovic A, et al. Reduced default mode network suppres-
sion during a working memory task in remitted major depres-
sion. J Psychiatr Res. 2015;64:9-18. PMID: 25801734.
